AI assistant
Sending…
Vera Therapeutics, Inc. — Director's Dealing 2021
Jul 15, 2021
31944_dirs_2021-07-15_d78857a2-284d-48ea-bd32-e585a602273e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-07-12
Reporting Person: Grant Sean (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities owned. | 0 | Direct |
More from Vera Therapeutics, Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25